Concurrent High PD-L1 Expression and CD8+ Immune Cell Infiltration Predict PD-1 Blockade Efficacy in Advanced EGFR-Mutant NSCLC Patients.
暂无分享，去创建一个
Y. Ohe | N. Yamamoto | S. Murakami | H. Horinouchi | N. Motoi | Y. Goto | Y. Okuma | Tatsuya Yoshida | Masayuki Shirasawa | Y. Shinno | K. Masuda | Y. Matsumoto | R. Shibaki | Yukiko Shimoda | Masahiro Torasawa | M. Shirasawa | M. Torasawa | T. Yoshida